Skip to main content

Animations

MJFF Publications

5821 - 5830 of 6324 Results
Title
Year
  • Year
  • 2015
  • 2024
  • 2023
  • 2017
  • 2021
  • 2021
  • 2021
  • 2021
  • 2025
  • 2020
  • Summary Details
    OPEN
    Title: Structural Characterization of LRRK2 Inhibitors
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/jm5018779
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disorders
    Journal Name: GeroScience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s11357-024-01120-4
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.13386
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI Study
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2017.00100
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Intronic Haplotypes in GBA Modify Age at Diagnosis of Parkinson's: Replication in a Subgroup
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28620
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Brain-specific inhibition of mTORC1 eliminates side effects resulting from mTORC1 blockade in the periphery and reduces alcohol intake in mice
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-24567-x
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Alpha‐Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.26089
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Demographic Influences on the Relationship Between Fatigue and Quality of Life in Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.13360
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implications
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1136/jnnp-2024-335364
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Deletion of DJ-1 in rats affects protein abundance and mitochondrial function at the synapse
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-020-70486-0
    Citation Count: 16
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.